Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
After publication of the original article [1], we were notified that an author’s family name has been erroneously spelled. Aditya Chandrokar should be replaced with Aditya Chandorkar.
Main Authors: | Ralph Rogers, Kapil Saharia, Aditya Chandorkar, Zoe F. Weiss, Kendra Vieira, Sophia Koo, Dimitrios Farmakiotis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | BMC Infectious Diseases |
Online Access: | https://doi.org/10.1186/s12879-020-4848-8 |
Similar Items
-
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
by: Ralph Rogers, et al.
Published: (2020-01-01) -
Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
by: Katya Prakash, et al.
Published: (2021-05-01) -
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
by: Posner Gary H, et al.
Published: (2011-01-01) -
Cytomegalovirus (CMV) Infection and Latency
by: Christine M. O’Connor
Published: (2021-03-01) -
Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
by: Helen M McGuire, et al.
Published: (2020-01-01)